Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Amortization (2016 - 2025)

MediWound has reported Amortization over the past 13 years, most recently at -$2.9 million for Q3 2025.

  • For Q3 2025, Amortization fell 144.98% year-over-year to -$2.9 million; the TTM value through Sep 2025 reached $3.5 million, down 68.22%, while the annual FY2024 figure was $15.3 million, 351.93% up from the prior year.
  • Amortization for Q3 2025 was -$2.9 million at MediWound, up from -$3.3 million in the prior quarter.
  • Over five years, Amortization peaked at $10.3 million in Q4 2022 and troughed at -$4.3 million in Q2 2023.
  • A 5-year average of $992176.5 and a median of $1.1 million in 2021 define the central range for Amortization.
  • Biggest five-year swings in Amortization: crashed 243.17% in 2022 and later soared 1292.58% in 2024.
  • Year by year, Amortization stood at $1.1 million in 2021, then soared by 810.65% to $10.3 million in 2022, then crashed by 117.73% to -$1.8 million in 2023, then skyrocketed by 278.41% to $3.3 million in 2024, then crashed by 188.36% to -$2.9 million in 2025.
  • Business Quant data shows Amortization for MDWD at -$2.9 million in Q3 2025, -$3.3 million in Q1 2025, and $3.3 million in Q4 2024.